Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Serretta

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 26, 1998
[Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients]V Serretta, P Vasile, V Falletta, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 1, 1988
[Prolonged medical therapy using mepartricin in prostatic hypertrophy. Results in 81 patients]V Serretta, C Pavone, D Di Trapani, et al.
Urology|November 4, 1998
Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patientsV Serretta, D Lo Presti, P Vasile, et al.
BJU International|September 27, 2003
Long-term outcome of antiandrogen monotherapy in advanced prostate carcinoma: 12-year results of a phase II studyV Serretta, G Daricello, N Dispensa, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicinM Pavone-Macaluso, M Tripi, G B Ingargiola, et al.
The Journal of Urology|April 25, 2008
Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunctionC Pavone, F Curto, G Anello, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 1, 1986
[Brief antimicrobial chemoprophylaxis in urology. A randomized clinical study (absence of treatment, cefotaxime, ceftriaxone)]M Tripi, V Serretta, D Melloni, et al.
Minerva Chirurgica|January 31, 1987
[Radiological anatomy of the renal artery and its branches]A Marconi, C Spinelli, F Aragona, et al.
The Journal of Urology|November 13, 2004
Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunctionC Pavone, F Curto, G Anello, et al.
Urologia Internationalis|April 24, 2001
PSA and second-line therapy of hormone refractory prostate carcinomaV Serretta, I Rizzo, G Contino, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 26, 1998
[Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients]V Serretta, P Vasile, V Falletta, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 1, 1988
[Prolonged medical therapy using mepartricin in prostatic hypertrophy. Results in 81 patients]V Serretta, C Pavone, D Di Trapani, et al.
Urology|November 4, 1998
Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patientsV Serretta, D Lo Presti, P Vasile, et al.
BJU International|September 27, 2003
Long-term outcome of antiandrogen monotherapy in advanced prostate carcinoma: 12-year results of a phase II studyV Serretta, G Daricello, N Dispensa, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicinM Pavone-Macaluso, M Tripi, G B Ingargiola, et al.
The Journal of Urology|April 25, 2008
Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunctionC Pavone, F Curto, G Anello, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 1, 1986
[Brief antimicrobial chemoprophylaxis in urology. A randomized clinical study (absence of treatment, cefotaxime, ceftriaxone)]M Tripi, V Serretta, D Melloni, et al.
Minerva Chirurgica|January 31, 1987
[Radiological anatomy of the renal artery and its branches]A Marconi, C Spinelli, F Aragona, et al.
The Journal of Urology|November 13, 2004
Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunctionC Pavone, F Curto, G Anello, et al.
Urologia Internationalis|April 24, 2001
PSA and second-line therapy of hormone refractory prostate carcinomaV Serretta, I Rizzo, G Contino, et al.
Pageof 6